Company Filing History:
1 out of 3 
1 out of 8 Years Active: 2021-2022
Title: Jussi Jernström: Innovator in Radiopharmaceuticals
Introduction
Jussi Jernström is a notable inventor based in Neufahrn, Germany. He has made significant contributions to the field of radiopharmaceuticals, particularly through his innovative methods for the production of highly purified germanium materials. With a total of 2 patents, Jernström's work is pivotal in advancing medical technologies.
Latest Patents
Jernström's latest patents include a method for the manufacture of highly purified 68Ge material for radiopharmaceutical purposes. This invention focuses on producing a germanium active pharmaceutical ingredient (Ge-API) solution that complies with good manufacturing practices (GMP). The method utilizes a germanium stock solution as raw material, which is purified from potential metal and organic impurities. The radiochemical method involves a twofold separation of germanium from these impurities using different adsorbent materials. The final Ge-API product meets regulatory requirements for GMP production of Ge/Ga generators.
Another significant patent is the development of a Ge/Ga generator designed for the continuous production of a gallium daughter nuclide. This generator specifically adsorbs the germanium parent nuclide to an inorganic support material, allowing for efficient decay to gallium. The use of metal oxides such as Vanadium, Niobium, and Tantalum as support materials enhances the generator's capacity, enabling it to load up to 8000 MBq of germanium.
Career Highlights
Throughout his career, Jernström has worked with prominent companies in the field, including ITM Isotope Technologies Munich SE and ITM Isotopen Technologien München AG. His expertise in radiopharmaceuticals has positioned him as a key figure in the industry, contributing to advancements that benefit medical applications.
Collaborations
Jernström has collaborated with notable professionals in his field, including Konstantin Zhernosekov and Mark Harfensteller. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Jussi Jernström's innovative contributions to the field of radiopharmaceuticals demonstrate his commitment to advancing medical technology. His patents reflect a deep understanding of the complexities involved in producing high-quality germanium materials for pharmaceutical use. Through his work, Jernström continues to influence the future of medical treatments and diagnostics.